PSS19 A PHARMACOECONOMIC EVALUATION OF PEGAPTANIB FOR THE MANAGEMENT OF AGE-RELATED MACULAR DEGENERATION (AMD) IN MEXICO
Abstract
Authors
GY Vega-Hernndez J Idrovo-Velandia R Rivas L Zapata J Venegas H Ramrez J Mould-Ouevedo G Davila-Loaiza